Tevogen Bio Holdings Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 552 | 1,283 | 1,052 | 129 | 345 |
| Receivables | 159 | 159 | N/A | N/A | N/A |
| TOTAL | $1,540 | $2,361 | $1,723 | $274 | $791 |
| Non-Current Assets | |||||
| PPE Net | 170 | 296 | 459 | N/A | N/A |
| Other Non-Current Assets | 2,673 | 804 | 3,324 | 356,864 | 352,061 |
| TOTAL | $2,843 | $1,101 | $3,783 | $356,864 | $352,061 |
| Total Assets | $4,383 | $3,462 | $5,506 | $357,138 | $352,852 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,590 | 5,450 | 3,418 | 351 | 59 |
| Accrued Expenses | 1,500 | 1,712 | 1,097 | N/A | N/A |
| TOTAL | $7,069 | $9,043 | $85,480 | $351 | $59 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,400 | 1,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,149 | 93 | 14,455 | 356,871 | 352,321 |
| TOTAL | $5,549 | $1,093 | $14,455 | $371,571 | $367,021 |
| Total Liabilities | $12,618 | $10,136 | $99,934 | $371,922 | $367,080 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,164 | 3,678 | 3,292 | 316 | 959 |
| Common Shares | 0 | 0 | 12 | 1 | 1 |
| Retained earnings | -139,661 | -113,385 | -99,658 | -14,785 | -14,229 |
| TOTAL | $-8,235 | $-6,674 | $-94,429 | $-14,783 | $-14,228 |
| Total Liabilities And Equity | $4,383 | $3,462 | $5,506 | $357,138 | $352,852 |